Tolerability and efficacy of Hexabrix in cerebral angiography.
In a double-blind study of 62 patients, Hexabrix was compared with Conray 60% in cerebral angiography. Both agents were injected into the same patient, the patient serving as his own control, and volumes injected into a single vessel were identical. Considerably less pain was experienced with Hexabrix. Changes in pulse, respiration and blood pressure were not significantly different. The two contrast media provided images of comparable quality.
D000328:Adult; D000368:Aged; D002533:Cerebral Angiography / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003287:Contrast Media; D004311:Double-Blind Method; D006801:Humans; D007463:Iodobenzoates; D007482:Iothalamate Meglumine; D007485:Ioxaglic Acid; D008875:Middle Aged; D010146:Pain / Q000209:etiology; D014283:Triiodobenzoic Acids
D003287:Contrast Media; D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; D007482:Iothalamate Meglumine; D007485:Ioxaglic Acid